News and Updates
CanPath and the Ontario Health Study at 15: Dr. Philip Awadalla on the future of Canada’s largest health research platform
Aug 19, 2024 // Study Updates
The OHS and CanPath have reached an important milestone-15 years of research! Dr. Philip Awadalla, as Executive Scientific Director of the OHS and National Scientific Director of CanPath, talks about how the two studies can be put to use in the next 15 years, including to help develop the tools for more aggressive cancer detection,
Cancer diagnoses studied among OHS participants
Aug 7, 2024 // Study Updates
No association found between depression and anxiety and many common cancers Living with depression and anxiety has been thought to put people at a higher risk for certain cancers. New research from a large international study, which includes data from thousands of OHS participants, is showing otherwise. In a paper published in August 2023, the
Boosting Immunity Insights: Collaborative Canadian Effort Contributes to Nationwide COVID-19 Immunity Study
Aug 14, 2023 // Study Updates
TORONTO, Monday, August 14, 2023 – Today, CanPath (the Canadian Partnership for Tomorrow’s Health) has contributed to the first peer-reviewed publication showcasing pan-Canadian seroprevalence estimates – published in the Canadian Medical Association Journal (CMAJ). Seroprevalence refers to how many people across Canada developed antibodies in response to infection or vaccination. Studies like this give us an idea
Provincial Variation in Colorectal Cancer Screening Adherence in Canada; evidence from the Canadian Partnership for Tomorrow’s Health (CanPath)
Jul 24, 2023 // Study Updates
Data from more than 158,000 Canadians, including almost 80,000 OHS participants, were used to examine why so few Canadians follow recommended screening guidelines for colorectal cancer, even though regular screening is shown to reduce incidents of the disease or death. Based on self-reported data from online questionnaires, it turns out only 47.7 percent of the
